2nd Quarter 2025: From Shock to Strength

From Shock to Strength Last quarter was nothing if not exciting. April opened with what market historians may someday call the Tariff Tantrum of 2025. On April 2, President Trump announced sweeping “reciprocal” duties that – at first blush – appeared large enough to upend global supply chains. Markets recoiled from this shocking announcement, knocking […]

JAG Growth Equity Thematic Insights: Q2 2025

June 2025 Investing in Transformation That Matters Beyond the Headlines, the AI Revolution Continues Although tariff policy, government spending, and politics have dominated the news coverage in recent weeks, we are closely monitoring longer-term catalysts for innovation and disruption including Artificial Intelligence (AI). Read more

JAG Fixed Income Thematic Insights: Q2 2025

June 2025 – Treasury Market Primer: Back to Textbook Basics? Summary As we enter the final weeks of Q2 – and at the risk of speaking too soon – several key markets may finish the quarter essentially unchanged from Q1. This seeming calm, however, obscures the roller-coaster of volatility investors endured in the first two […]

2nd Quarter 2024: The Concentration Conundrum

The Concentration Conundrum Enthusiasm for Artificial Intelligence (AI) once again powered the broad market higher last quarter, as the S&P 500 generated solid gains. By market capitalization, large caps outperformed small caps in Q2, as they did in the first quarter of 2024. On a sector level, performance was decidedly mixed. Five of the 11 […]

JAG Team Insights — Getting (Re) Familiar with Discount Bonds

Bloomberg US Aggregate Index: Average Price

November 15, 2023 Summary Rising interest rates have led to steep price declines in bond markets. Some bonds trade at deep price discounts even though their issuer’s credit quality remains strong. Bonds purchased at a market discount may offer a unique tax-deferral opportunity for investors. Read more…

JAG Team Insights — Fixing Your Fixed Income Allocation: Back to Basics

Chart showing Fed Funds Target Rate During Hiking Cycles 1986 - 2023

September 30, 2023 Capital markets have been put through the wringer since the Fed started their rake hike cycle, resulting in many fixed income portfolios failing to achieve their stabilizing role in investors’ asset allocations. The Fed, by its own admission, was late recognizing the severity and persistence of inflation. Behind the curve, but determined […]

3rd Quarter 2023: Rising Rates Create Opportunities…And Risks

Cartoon showing a man and woman sitting in front of a bank loan officer.

Market Overview Stocks had a strong start to the third quarter before pulling back in August and September. Overall, the S&P 500 ended the quarter with modest losses, in part attributable to another spike higher in interest rates. In our opinion, the resilience in the US economy could be contributing to the recent market volatility. […]

2nd Quarter 2023: The Return of Guarded Optimism

Cartoon showing a man with a smiley face and the headline "The Return of Guarded Optimism

Market Overview Last quarter began with markets still in the throes of the regional bank crisis following the March failures of Silicon Valley Bank and Signature Bank, which was followed on May 1st by the failure of First Republic Bank. Although investors feared a broader contagion in the regional banking industry, the Federal Deposit Insurance […]

JAG Team Insights — Obesity Drug Craze Approaching Critical Milestone

Graphic chart showing disrupting disease progression in diabetes and obesity to improve outcomes

June 2023 In recent years, a class of drugs known as GLP-1 agonists have experienced an unprecedented rise in popularity and captured the attention of doctors, patients, and investors alike. GLP-1 is short for glucagon-like peptide 1, a natural hormone produced by the human body which the drugs are designed to mimic. For the general […]

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

eMoney

eMoney is an industry-leading financial planning platform designed to help advisors, planners, and RIAs deliver personalized, comprehensive financial advice to clients across all stages of life.

Nitrogen

Nitrogen is a client-engagement and advisor platform built to bring clarity, quantification, and alignment to risk tolerance and portfolio construction. It uses a proprietary system that simplifies risk into a single, objective metric — the Risk Number® — allowing advisors and clients to speak the same language about risk, rather than relying on vague, subjective labels like “moderate” or “aggressive.”

Important Notice

This document contains investment performance information and is intended solely for Institutional Investors and Financial Intermediaries.

By clicking "Accept" below, you confirm that you are:

This material is not intended for retail investors and should not be distributed or relied upon by any person other than the intended audience. Performance data presented may be based on past results, which do not guarantee future performance.

If you do not meet the qualifications above, please click "Decline" to return to the homepage.

You are now leaving

www.jagcap.com